Status:
COMPLETED
Efficacy of Multimodal Analgesia Following Hip Arthroscopy
Lead Sponsor:
Western University, Canada
Conditions:
Hip Pain Chronic
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of the full study is to determine whether multimodal analgesia for hip arthroscopy will reduce post-operative pain scores, narcotic consumption and hospital length-of-stay. To do this, the...
Detailed Description
This pilot study will be a randomized controlled trial, where the surgical team, data collector, and patient will be blinded to the treatment received. The investigators will include any patient betwe...
Eligibility Criteria
Inclusion
- any patient between the ages of 18 and 60 years undergoing hip arthroscopy by one of three fellowship-trained hip arthroscopists
Exclusion
- radiographic signs of osteoarthritis (Tönnis grade 2 or higher), an American Society of Anesthesiologists (ASA) classification of 3 or higher,
- allergy to sulfa-based drugs,
- adverse reactions to any of the potential study medications, or a
- history of chronic pain, substance abuse or
- pregnancy
Key Trial Info
Start Date :
April 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03351439
Start Date
April 6 2018
End Date
September 30 2021
Last Update
October 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fowler Kennedy Sport Medicine Clinic
London, Ontario, Canada, N6A 3K7